~~<i id='CD607C4E6F'><strike id='CD607C4E6F'><tt id='CD607C4E6F'><pre id='CD607C4E6F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

hotspot

author：explore 2025-08-26 01:21:22 - browse：7

A device component from Paradromics Inc., one of the main brain-computer interface players racing to get to market. Courtesy Paradromics Inc.

Rodney Gorham loves fast, flashy cars: His WhatsApp profile picture is a bright yellow Corvette Stingray. “I don’t get to drive it anymore,” Gorham told STAT in a text.

Gorham, a 63-year-old living in Australia, has amyotrophic lateral sclerosis. He can’t speak, and can move his hands and legs only a little. But he is able to control his computer with his thoughts, aided by a brain-computer interface developed by the startup Synchron.

“It has been exciting to be involved,” Gorham wrote.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Orangutan used medicinal plant to treat wound, first time ever seen

hotspot

knowledge

leisure time

focus

knowledge

YUKIIWAMURA/AFPviaGettyImagesWhilemanypeopleimmediatelypictureyoungadultswhenthinkingaboutthecurrent

WSS

FTC falls short on scrutinizing hospital mergers, study says

Cell therapy fails to slow type 1 diabetes, but safety is established

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Cholera vaccine supply gets boost as demand surges globally

Wearables generate powerful data but its not useful to doctors, yet

explore

hotspot

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

Medicare details structure of new drug price negotiation program

Cell therapy fails to slow type 1 diabetes, but safety is established

Psychedelics group wrestles with new pharma identity

Diversity in clinical trials starts with building trust, experts say

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Solving academic medical centers' existential crisis

knowledge

Cancer researcher Catriona Jamieson is sending tumors into space

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Q&A: Jennifer Adair on making gene therapy available globally

H5N1 bird flu virus started spreading in cows in Texas in December

With measles on the rise, a personal story of a devastating disease

Cytokinetics CEO stresses company can launch heart drug on its own

leisure time

focus

focus

knowledge